196
Views
1
CrossRef citations to date
0
Altmetric
Articles

Ameliorating Effects of Four-Week Fiber-Multivitamin Combination Treatment on Low-Density Lipoprotein Cholesterol, Total Cholesterol, and Apolipoprotein B Profiles in Hypercholesterolemic Participants

, MSc, PhD, , MD, MSc, , MSc, PhD, , MSc, PhD & , MSc
Pages 173-183 | Received 29 May 2018, Accepted 26 Jun 2018, Published online: 31 Oct 2018

References

  • Anderson JW, Allgood LD, Lawrence A, Altringer LA, Jerdack GR, Hengehold DA, Morel JG. 2000. Cholesterol lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr. 71(2):472–479. doi:10.1093/ajcn/71.2.472.
  • Cicero AF, Ferroni A, Ertek S. 2012. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects. Expert Opin Drug Saf. 11(5):753–766. doi:10.1517/14740338.2012.705827.
  • Cicero AFG, Fogacci F, Colletti A. 2017. Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach. Food Funct. 8(6):2076–2088. doi:10.1039/c7fo00178a.
  • Hunninghake DB, Miller VT, La Rosa JC, Kinosian B, Brown V, Howard WJ, DiSerio FJ, O'Connor RR. 1994. Hypocholesterolemic effects of a dietary fiber supplement. Am J Clin Nutr. 59(5):1050–1054. doi:10.1093/ajcn/59.5.1050.
  • Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard P-M, Dagenais GR, Despré, SJP. 1996. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Que´bec cardiovascular study. Circulation. 94(3):273–278. https://doi.org/10.1161/01.CIR.94.3.273.
  • Pirro M, Vetrani C, Bianchi C, Mannarino MR, Bernini F, Rivellese AA. 2017. Joint position statement on “nutraceuticals for the treatment of hypercholesterolemia” of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA). Nutr Metab Cardiovasc Dis. 27(1):2–17. doi:10.1016/j.numecd.2016.11.122.
  • Ramírez-Vélez R, Correa-Bautista JE, Ojeda-Pardo ML, Sandoval-Cuellar C, García-Hermoso A, Carrillo HA, González-Ruíz K, Prieto-Benavides DH, Tordecilla-Sanders A, Martink˙enas A, et al. 2018. Optimal Adherence to a Mediterranean Diet and High Muscular Fitness Are Associated with a Healthier Cardiometabolic Profile in Collegiate Students2018. Nutrients. 10(4):511. doi:10.3390/nu10040511.
  • Sprecher DL, Pearce GL. 2002. Fiber-Multivitamin combination therapy: a beneficial influence on Low-Density Lipoprotein and homocysteine. Metabolism. 51(9):1166–1170. PMID: 12200762.
  • Thorning TK, Raziani F, Bendsen NT, Astrup A, Tholstrup T, Raben A. 2015. Diets with high-fat cheese, high-fat meat, or carbohydrate on cardiovascular risk markers in overweight postmenopausal women: a randomized crossover trial. Am J Clin Nutr. 102(3):573–581. doi:10.3945/ajcn.115.109116.
  • Verdegem PJE. 2007. Viscous soluble fiber combined with phytosterol and policosanol reduced LDL-cholesterol and indreases HDL-cholesterol hypercholesterolemia. Curr Topics in Nutraceut Res. 5(1):1–6. http://www.nchpjournals.com/journals/manuscript.php?msid=500.
  • Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. 2001. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 358(9298):2026–2033. doi:10.1016/S0140-6736(01)07098-2.
  • Wei Z-h, Wang H, Chen X-y, Wang B-S, Rong Z-X, Wang B-S, Su B-h, Chen H-Z. 2009. Time-and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials. Eur J Clin Nutr. 63(7):821–827. doi:10.1038/ejcn.2008.49.
  • Wilson DE, Lees RS. 1972. Metabolic relationships among the plasma lipoproteins: reciprocal changes in the concentration of very low and low density lipoprotein in man. J Clin Invest. 51(5):1051–1057. doi:10.1172/JCI106896.
  • World Health Organization. Global Health Observatory (GHO) data. 2018. Raised Cholesterol: Situation and trends. [accessed 2018 April 30]. http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/.
  • Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 364(9438):937–952. https://doi.org/10.1016/S0140-6736(04)17018-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.